Lorukafusp alfa
Based on 1 Customer Validation
Lorukafusp alfa (14.18 mAb; hu14.18-IL2) is an immunocytokine consisting of the humanized 14.18 anti-GD2 mAb linked to IL210. Lorukafusp alfa has activity mediated by activation of antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity via the binding of hu14.18-IL2 to GD2 on the tumor cell surface, followed by binding to Fc receptors on effector cells along with activation of NK and T cells via IL2 receptor binding. Lorukafusp alfa has anti-tumor activity.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza: 97.8%
- No. CAS: 2131168-99-3
- Peso molecular:175.6 kDa
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Human IgG1 kappa
Human
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
ganglioside GD2
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
Human IgG1 kappa
ELISA, FACS, Functional assay
-
Immobilized Human IL-2R-alpha/CD25 Protein (HEK293, C-His, HY-P70628) can bind Lorukafusp alfa. The EC50 for this effect is 5.85 ng/mL. -
Immobilized Ganglioside GD2 (HY-165740) can bind Lorukafusp alfa. The EC50 for this effect is 365.7 ng/mL.
Chemical Information
-
No. CAS 2131168-99-3
-
Appearance Liquid
-
Peso molecular 175.6 kDa
-
Color Colorless to light yellow
-
SMILES
[Lorukafusp alfa]
-
Synonyms
APN-301; hu14.18-IL2; EMD 273063
-
Envío
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
-
Ficha de datos (256 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)